BioSpace News Archive

A retrospective analysis – reported in the journal Cancer by Judith Malmgren, PhD, and co-authors – studied patients in the Surveillance, Epidemiology, and End Results (SEER) 9 population and an institutional cohort with de novo metastatic breast cancer (MBC), which is a first diagnosis of breast cancer that is stage IV.

StretchLab, a one-on-one assisted stretching concept that launched as national franchise just last year has signed its 250th franchise agreement, catapulting the brand into dozens of new markets and proving mass appeal from teenagers to 90-year-olds and anyone in between.

SwabTek™, leaders in the narcotics and explosives presumptive testing industry, will introduce the world’s ONLY DRY reagent narcotics and explosives field test kits developed for the law enforcement community (federal, state and local as well as School Resource Officers and the aviation industry) at the 2019 IACP (International Association of Chiefs of Police) Conference and Exposition in Chicago, IL, October 26–29.

ABC Financial (ABC), the leading software and payment processing provider to the health and fitness industry, today announced their preferred partnership with Trek CCM, LLC.

Ambry Genetics® (Ambry), a leading clinical genetics company, announced today the publication in JAMA Network Open of a study on retrospective RNA genetic testing for hereditary cancer risk

iCare Health Solutions, LLC has announced that its Diabetic Retinal Exam patient outreach program has helped five of its Florida-based Medicare Advantage partners earn the CMS Five-Star rating for their Healthcare Effectiveness Data and Information Set Diabetic Retinal Exam measure.

Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it will release third-quarter 2019 financial results on Wednesday, November 6, 2019, after the close of markets.

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of high-grade cannabis is pleased to announce that it has obtained the licence for cannabis research and development from INFARMED, the Portuguese National Authority of Medicines and Health Products

Soleno Therapeutics, Inc. (SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the pricing of an underwritten public offering of 11,166,667 shares of its common stock at a public offering price of $1.20 per share.

The Israeli start-up Laminate Medical Technologies, developer of the VasQ™ External Vascular Support Device for arteriovenous fistulas in patients requiring dialysis, today announces the completion of a capital raising following an investment from the London-based Valiance Asset Management, through its Luxembourg domiciled Life Sciences Global Investment Fund, in addition to the investment announced earlier this year.